Large-scale testing (Phase 3)UnknownNCT01352091What this trial is testingAdjuvant AI Combined With ZoladexWho this might be right forBreast Cancer Fudan University 670
Testing effectiveness (Phase 2)Looking for participantsNCT06927180What this trial is testingSHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BCWho this might be right forBreast Cancer Early Stage Breast Cancer (Stage 1-3) Henan Cancer Hospital 180
Not applicableUnknownNCT05656079What this trial is testingTo Evaluate the Cardiac Safety of Pegylated Liposomal Doxorubicin Concurrently Plus Trastuzumab and Pertuzumab in the Adjuvant Setting for Early-stage HER-2-positive Breast Cancer: a Multicenter, Randomized Controlled Clinical StudyWho this might be right forBreast Cancer Shanghai Pudong Hospital 204
Not applicableStudy completedNCT04659980What this trial is testingPreventing Taxane-related Peripheral Neuropathy, Pain and Nail Toxicity: A Prospective Self-controlled Trial Comparing Hilotherapy With Frozen Gloves in Early Breast CancerWho this might be right forBreast Cancer Universitaire Ziekenhuizen KU Leuven 62
Not applicableUnknownNCT05892146What this trial is testingStrategy Therapy on Cancer Therapy-Related Cardiac DysfunctionWho this might be right forChemotherapeutic ToxicityCardiotoxicityHeart Failure+2 more National Cheng-Kung University Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT05929768What this trial is testingShorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+2 more SWOG Cancer Research Network 2,400
Not applicableEnrolling By InvitationNCT06924788What this trial is testingVideo-Conferenced Stress Management and Relaxation Training (VSMART) For Alabama Breast Cancer SurvivorsWho this might be right forBreast Cancer Early Stage Breast Cancer (Stage 1-3) University of Alabama at Birmingham 25
Testing effectiveness (Phase 2)Looking for participantsNCT06000917What this trial is testingNeoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast CancerWho this might be right forBreast CancerNeoadjuvant Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 62
Not applicableStudy completedNCT07042568What this trial is testingThe Effect of Education Given on Preventing Mouth Ulcers in Women With Breast CancerWho this might be right forBreast Cancer Early Stage Breast Cancer (Stage 1-3)Chemotherapy Trakya University 85
Not applicableUnknownNCT06332976What this trial is testingPrefeRences And ChemoTherapy In Breast Cancer patiEntsWho this might be right forFemale Breast Cancer European Institute of Oncology 450
Not applicableLooking for participantsNCT06225505What this trial is testingEarly Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)Who this might be right forTriple Negative Breast Cancer Institut Curie 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT05710666What this trial is testingNeoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)Who this might be right forHER2-positive Breast Cancer Cancer Trials Ireland 11
Testing effectiveness (Phase 2)Looking for participantsNCT07159451What this trial is testingA Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast CancerWho this might be right forBreast Cancer Gustave Roussy, Cancer Campus, Grand Paris 140
Large-scale testing (Phase 3)Looking for participantsNCT03201861What this trial is testingAddition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk WomenWho this might be right forTubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast RenJi Hospital 762
Not applicableLooking for participantsNCT06185569What this trial is testingFREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided TherapyWho this might be right forBreast Cancer Centre Hospitalier Universitaire de Besancon 4,500
Large-scale testing (Phase 3)Ended earlyNCT06038539What this trial is testingEfficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast CancerWho this might be right forHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Biocon Biologics UK Ltd 55
Early research (Phase 1)Study completedNCT02738970What this trial is testingA Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)Who this might be right forEarly Breast Cancer Hoffmann-La Roche 88
Not applicableEnded earlyNCT02771795What this trial is testingA Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BCWho this might be right forBreast Neoplasms Samsung Bioepis Co., Ltd. 538
Not applicableUnknownNCT05142202What this trial is testingHigh Five (HiFi) Accelerated Partial Breast Irradiation StudyWho this might be right forBreast Cancer The Greater Poland Cancer Centre 147
Post-approval studies (Phase 4)Study completedNCT05365230What this trial is testingTrial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast CancerWho this might be right forBreast Cancer Ottawa Hospital Research Institute 261